How many insider trades does FilingIQ track for SGMT?

FilingIQ tracks 72 Form 4 insider transactions for SGMT (Sagimet Biosciences Inc.), covering filings from Jul 20, 2023 onwards. 9 of those are dated within the last 90 days.

Are SGMT insiders net buyers or net sellers?

Across the full Form 4 history for SGMT, 5 transactions (7%) were open-market purchases and 18 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SGMT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is SGMT in?

Sagimet Biosciences Inc. (SGMT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $165.70M.

SGMT insider trading

Healthcare

Sagimet Biosciences Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

7% / 25%

Market cap

$165.70M

About Sagimet Biosciences Inc.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs, such as various solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Company website: www.sagimet.com

SGMT insider activity at a glance

FilingIQ tracks 72 insider transactions for SGMT in filings since Jul 20, 2023. The most recent transaction is dated Aug 14, 2026.

Across the full history, 5 open-market purchases and 18 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SGMT insider trades is 51.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SGMT trades on FilingIQ Raw filings on SEC EDGAR

Latest SGMT Form 4 filings

Happel David President & CEO

S Jul 22, 2026

Rozek Elizabeth Chief Legal & Admin. Officer

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for SGMT?: FilingIQ tracks 72 Form 4 insider transactions for SGMT (Sagimet Biosciences Inc.), covering filings from Jul 20, 2023 onwards. 9 of those are dated within the last 90 days.
Are SGMT insiders net buyers or net sellers?: Across the full Form 4 history for SGMT, 5 transactions (7%) were open-market purchases and 18 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SGMT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is SGMT in?: Sagimet Biosciences Inc. (SGMT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $165.70M.

Methodology & sources

Every SGMT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.